FoxO proteins in pancreatic β-cells as potential therapeutic targets in diabetes

References

• Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev.14, 142–146 (2000).
   PubMed Web of Science ®Google Scholar
• Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene24(50), 7410–7425 (2005).
   PubMed Web of Science ®Google Scholar
• Glauser DA, Schlegel W. The emerging role of FOXO transcription factors in pancreatic β cells. J. Endocrinol.193(2), 195–207 (2007).
   PubMedGoogle Scholar
• van der Horst A, Burgering BM. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol.8(6), 440–450 (2007).
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell96(6), 857–868 (1999).
   PubMed Web of Science ®Google Scholar
• Essers MA, Weijzen S, de Vries-Smits AM et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J.23(24), 4802–4812 (2004).
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Accili D. All roads lead to FoxO. Cell Metab.1(4), 215–216 (2005).
   PubMedGoogle Scholar
• Lehtinen MK, Yuan Z, Boag PR et al. A conserved MST–FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell125(5), 987–1001 (2006).
   PubMed Web of Science ®Google Scholar
• Brunet A, Sweeney LB, Sturgill JF et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science303(5666), 2011–2015 (2004).
   PubMed Web of Science ®Google Scholar
• Kitamura YI, Kitamura T, Kruse JP et al. FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab.2(3), 153–163 (2005).
   PubMed Web of Science ®Google Scholar
• Matsuzaki H, Daitoku H, Hatta M, Tanaka K, Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl Acad. Sci. USA100(20), 11285–11290 (2003).
   PubMed Web of Science ®Google Scholar
• van der HorstA, de Vries-Smits AM, Brenkman AB et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol.8(10), 1064–1073 (2006).
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell2(1), 81–91 (2002).
   PubMed Web of Science ®Google Scholar
• Buteau J, Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic β-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J. Biol. Chem.282(1), 287–293 (2007).
   PubMed Web of Science ®Google Scholar
• Mercado GE, Barr FG. Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances. Curr. Mol. Med.7(1), 47–61 (2007).
   PubMed Web of Science ®Google Scholar
• So CW, Cleary ML. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood101(2), 633–639 (2003).
   PubMedGoogle Scholar
• Hu MC, Lee DF, Xia W et al. IkB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell117(2), 225–237 (2004).
   PubMed Web of Science ®Google Scholar
• Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene24(11), 1924–1935 (2005).
   PubMedGoogle Scholar
• Paik JH, Kollipara R, Chu G et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell128(2), 309–323 (2007).
   PubMed Web of Science ®Google Scholar
• Ni YG, Berenji K, Wang N et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation114(11), 1159–1168 (2006).
   PubMed Web of Science ®Google Scholar
• Bakker WJ, Blazquez-Domingo M, Kolbus A et al. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J. Cell Biol.164(2), 175–184 (2004).
   PubMed Web of Science ®Google Scholar
• Bakker WJ, van Dijk TB, Parren-van Amelsvoort M et al. Differential regulation of Foxo3a target genes in erythropoiesis. Mol. Cell. Biol.27(10), 3839–3854 (2007).
   PubMedGoogle Scholar
• Nakae J, Kitamura T, Kitamura Y et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell4(1), 119–129 (2003).
   PubMed Web of Science ®Google Scholar
• Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J. Cell Biol.162(4), 535–541 (2003).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Kitamura YI, Funahashi Y et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Invest.117(9), 2477–2485 (2007).
   PubMed Web of Science ®Google Scholar
• Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab.16(4), 183–189 (2005).
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Donovan J et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1a interaction. Nature423(6939), 550–555 (2003).
   PubMed Web of Science ®Google Scholar
• Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem. J.375(Pt 2), 365–371 (2003).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Nakae J, Kitamura Y et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J. Clin. Invest.110(12), 1839–1847 (2002).
   PubMed Web of Science ®Google Scholar
• Kim MS, Pak YK, Jang PG et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci.9(7), 901–906 (2006).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Feng Y, Ido Kitamura Y et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med.12(5), 534–540 (2006).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Ido Kitamura Y. Role of FoxO proteins in pancreatic β cells. Endocr. J.54(4), 507–515 (2007).
   PubMed Web of Science ®Google Scholar
• Contreras JL, Smyth CA, Bilbao G et al. Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation74(8), 1063–1069 (2002).
   PubMedGoogle Scholar
• Del Guerra S, Lupi R, Marselli L et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes54(3), 727–735 (2005).
   PubMedGoogle Scholar
• McKinnon CM, Ravier MA, Rutter GA. FoxO1 is required for the regulation of preproglucagon gene expression by insulin in pancreatic alphaTC1–9 cells. J. Biol. Chem.281(51), 39358–39369 (2006).
   PubMedGoogle Scholar
• Dickson LM, Rhodes CJ. Pancreatic β-cells growth and survival in the onset of Type 2 diabetes: a role for protein kinase B in the Akt? Am. J. Physiol. Endocrinol. Metab.287(2), E192–E198 (2004).
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA. Glucose promotes pancreatic islet β-cells survival through a PI 3-kinase/Akt-signaling pathway. Am. J. Physiol. Endocrinol. Metab.283(4), E784–E793 (2002).
   PubMedGoogle Scholar
• Li L, El-Kholy W, Rhodes CJ, Brubaker PL. Glucagon-like peptide-1 protects β cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia48(7), 1339–1349 (2005).
   PubMed Web of Science ®Google Scholar
• Wang Q, Li L, Xu E et al. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 β cells. Diabetologia47(3), 478–487 (2004).
   PubMed Web of Science ®Google Scholar
• Nakae J, Biggs WH 3rd, Kitamura T et al. Regulation of insulin action and pancreatic β-cells function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet.32(2), 245–253 (2002).
   PubMed Web of Science ®Google Scholar
• Hashimoto N, Kido Y, Uchida T et al. Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass. Nat. Genet.38(5), 589–593 (2006).
   PubMedGoogle Scholar
• Okamoto H, Hribal ML, Lin HV et al. Role of the forkhead protein FoxO1 in β cell compensation to insulin resistance. J. Clin. Invest.116(3), 775–782 (2006).
   PubMedGoogle Scholar
• Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cells mass. Diabetes55(5), 1190–1196 (2006).
   PubMed Web of Science ®Google Scholar
• Kim SJ, Winter K, Nian C et al. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cells survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J. Biol. Chem.280(23), 22297–22307 (2005).
   PubMed Web of Science ®Google Scholar
• Martinez SC, Cras-Meneur C, Bernal-Mizrachi E, Permutt MA. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet {β}-cell. Diabetes55(6), 1581–1591 (2006).
   PubMed Web of Science ®Google Scholar
• Kawamori D, Kaneto H, Nakatani Y et al. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem.281(2), 1091–1098 (2006).
   PubMedGoogle Scholar
• Kaneto H, Nakatani Y, Kawamori D et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cells dysfunction and insulin resistance. Int. J. Biochem. Cell Biol.37(8), 1595–1608 (2005).
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov.4(12), 988–1004 (2005).
   PubMed Web of Science ®Google Scholar
• Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem.277(41), 38013–38020 (2002).
   PubMed Web of Science ®Google Scholar
• Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem.279(13), 12755–12762 (2004).
   PubMed Web of Science ®Google Scholar
• Samuels Y, Diaz LA Jr, Schmidt-Kittler O et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell7(6), 561–573 (2005).
   PubMed Web of Science ®Google Scholar
• Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal.18(12), 2262–2271 (2006).
   PubMed Web of Science ®Google Scholar
• Noske A, Kaszubiak A, Weichert W et al. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer. Cancer Lett.246(1–2), 190–200 (2007).
   PubMed Web of Science ®Google Scholar
• An HJ, Cho NH, Yang HS et al. Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells. J. Pathol.212(2), 161–169 (2007).
   PubMed Web of Science ®Google Scholar
• Brunet A, Park J, Tran H et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol.21(3), 952–965 (2001).
   PubMed Web of Science ®Google Scholar
• Park JY, Lin PY, Weiss RH. Targeting the PI3K–Akt pathway in kidney cancer. Expert Rev. Anticancer Ther.7(6), 863–870 (2007).
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Ahmad N. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer. Toxicol. Appl. Pharmacol.224(3), 360–368 (2006).
   PubMedGoogle Scholar
• Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol.21(10), 3534–3546 (2001).
   PubMedGoogle Scholar
• Schwab TS, Madison BB, Grauman AR, Feldman EL. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells. Apoptosis10(4), 831–840 (2005).
   PubMed Web of Science ®Google Scholar
• Kau TR, Schroeder F, Ramaswamy S et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell4(6), 463–476 (2003).
   PubMed Web of Science ®Google Scholar
• Schroeder FC, Kau TR, Silver PA, Clardy J. The psammaplysenes, specific inhibitors of FOXO1a nuclear export. J. Nat. Prod.68(4), 574–576 (2005).
   PubMedGoogle Scholar
• Heyliger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science227(4693), 1474–1477 (1985).
   PubMed Web of Science ®Google Scholar
• Schmid AC, Byrne RD, Vilar R, Woscholski R. Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett.566(1–3), 35–38 (2004).
   PubMed Web of Science ®Google Scholar
• Lazar DF, Saltiel AR. Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat. Rev. Drug Discov.5(4), 333–342 (2006).
   PubMed Web of Science ®Google Scholar
• Samuel VT, Choi CS, Phillips TG et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes55(7), 2042–2050 (2006).
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Furukawa-Hibi Y, Chen C et al. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med.16(2), 237–243 (2005).
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov.5(6), 493–506 (2006).
   PubMed Web of Science ®Google Scholar
• Milne JC, Lambert PD, Schenk S et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature450(7170), 712–716 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev.19(4), 477–490 (1998).
   PubMed Web of Science ®Google Scholar
• Butler AE, Janson J, Bonner-Weir S et al. β-cells deficit and increased β-cells apoptosis in humans with type 2 diabetes. Diabetes52(1), 102–110 (2003).
   PubMed Web of Science ®Google Scholar
• Rhodes CJ. Type 2 diabetes-a matter of β-cells life and death? Science307(5708), 380–384 (2005).
   PubMed Web of Science ®Google Scholar
• Fridlyand LE, Philipson LH. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic β-cells? Diabetes53(8), 1942–1948 (2004).
   PubMed Web of Science ®Google Scholar
• Baggio LL, Drucker DJ. Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu. Rev. Med.57, 265–281 (2006).
   PubMed Web of Science ®Google Scholar
• Drucker DJ. The biology of incretin hormones. Cell Metab.3(3), 153–165 (2006).
   PubMed Web of Science ®Google Scholar
• Hatipoglu B, Benedetti E, Oberholzer J. Islet transplantation: current status and future directions. Curr. Diab. Rep.5(4), 311–316 (2005).
   PubMedGoogle Scholar
• Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol. Biol.333, 47–104 (2006).
   PubMedGoogle Scholar
• Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell117(4), 421–426 (2004).
   PubMed Web of Science ®Google Scholar
• Aikin R, Hanley S, Maysinger D et al. Autocrine insulin action activates Akt and increases survival of isolated human islets. Diabetologia49(12), 2900–2909 (2006).
   PubMedGoogle Scholar
• Aikin R, Maysinger D, Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology145(10), 4522–4531 (2004).
   PubMed Web of Science ®Google Scholar
• Davalli AM, Scaglia L, Zangen DH et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes45(9), 1161–1167 (1996).
   Google Scholar
• Marinkovic D, Zhang X, Yalcin S et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Invest.117(8), 2133–2144 (2007).
   PubMed Web of Science ®Google Scholar
• Lock LT, Tzanakakis ES. Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng.13(7), 1399–1412 (2007).
   PubMedGoogle Scholar
• Kato M, Yuan H, Xu ZG et al. Role of the Akt/FoxO3a pathway in TGF-β1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol.17(12), 3325–3335 (2006).
   PubMedGoogle Scholar